About
Brian Albrecht is the Partner and Head of Drug Discovery at Related Sciences. He was the former Principal at Third Rock Ventures. Brian Albrecht joined Third Rock Ventures in 2015 and brings more than 12 years of biopharmaceutical drug discovery experience to the firm. As a principal, Brian focuses on new company formation and drug discovery due diligence. Prior to joining Third Rock, Brian built and led the medicinal chemistry department at Constellation Pharmaceuticals – pioneering epigenetic drug discovery research. As one of the first four Constellation employees, he was instrumental in building the foundation of the drug discovery product engine and was given increasing amounts of responsibility throughout his tenure. Under his leadership, Constellation’s medicinal chemistry group delivered two clinical assets. Prior to Constellation, Brian was a member of the medicinal chemistry department at Amgen. Brian is listed as a co-inventor on over 20 issued patents and a co-author on
Position in the VCSift Database
- • 3 investors at Related Sciences are tracked.
- • 1 investors hold the Partner and Head of Drug Discovery role in VCSift. Brian Albrecht is one of them.
- • 2,293 investors are based in Boston, Massachusetts, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- Boston, US
Contact Information
Find more investors like Brian
Search Investors